Advertisement
There is currently no generic version of Tudorza Pressair (aclidinium), an inhaled drug used for long-term treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD). Tudorza Pressair was approved in 2012 by the Food and Drug Administration.
Continue Learning about Pharmacology
Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.